NYSE:KVUE

Kenvue (KVUE) Stock Forecast, Price & News

$27.23

+0.19 (+0.70%)

(As of 05/19/2023 08:48 PM ET)

Compare

Today's Range: $26.69
▼
$27.26
50-Day Range: N/A
52-Week Range: $25.25
▼
$27.80

Volume: 1.79 million shs
Average Volume: 5.61 million shs
Market Capitalization: $51.44 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Financials Insider Trades Headlines SEC Filings Social Media

About Kenvue (NYSE:KVUE) Stock

Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J.

Receive KVUE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kenvue and its competitors with MarketBeat's FREE daily newsletter.

KVUE Stock News Headlines

May 9, 2023 | marketbeat.com

J&J Kenvue Spinoff Aims To Give Investors A Healthy Return

Johnson & Johnson spinoff Kenvue had the biggest IPO since 2021, raising $3.8 billion. Kenvue's brands include Band-Aid, Tylenol, Neutrogena and Listerine.

May 19, 2023 | msn.com

Kenvue Just IPO'd, but Is the Stock a Buy?

May 22, 2023 | Behind the Markets (Ad)

"Chilling War Games Show US Forces Crushed" – FOX NEWS

=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>

May 15, 2023 | americanbankingnews.com

Insider Buying: Kenvue Inc. (NYSE:KVUE) Director Purchases $525,200.00 in Stock

May 8, 2023 | finance.yahoo.com

Kenvue Announces Closing of Initial Public Offering

May 6, 2023 | reuters.com

J&J's Kenvue eyes $47 billion valuation in biggest US IPO since 2021

May 6, 2023 | forbes.com

Kenvue IPO: Profitable Company, Expensive Stock

May 6, 2023 | msn.com

J&J spinout Kenvue raises $3.8B through upsized IPO, making it largest of year

May 22, 2023 | Legacy Research (Affiliate) (Ad)

Central Bank: “Final stage” beginning now

Our financial system is about to be transformed in a way that would’ve been unthinkable just a few years ago. And almost nobody is prepared for the chaos that follows.

May 5, 2023 | benzinga.com

Kenvue Stock Up 5.37% Since IPO

May 5, 2023 | finance.yahoo.com

Kenvue to Begin Trading on the New York Stock Exchange

May 5, 2023 | seekingalpha.com

Kenvue: A Look At The Johnson Spinoff

May 5, 2023 | msn.com

J&J spinout Kenvue shares climb 22% following $3.8B upsized IPO (update)

May 5, 2023 | msn.com

J&J spinoff Kenvue prices IPO at $22, toward the top end of expected range

May 5, 2023 | msn.com

Kenvue: Profitable Company, Expensive Stock

May 5, 2023 | cnbc.com

J&J's consumer-health spinoff Kenvue jumps 22% in public market debut

May 5, 2023 | seekingalpha.com

Kenvue Stock Surges On Trading Debut

April 25, 2023 | seekingalpha.com

IPO Update: Kenvue Seeks $3.25 Billion IPO

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive KVUE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kenvue and its competitors with MarketBeat's FREE daily newsletter.

KVUE Company Calendar

Today: 5/21/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: N/A
Sub-Industry: N/A
Sector: Consumer Staples
Current Symbol: NYSE:KVUE
CUSIP: N/A
CIK: 1944048
Web: N/A
Phone: N/A
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 1,888,970,000
Free Float: N/A
Market Cap: $51.44 billion
Optionable: Not Optionable
Beta: N/A

Key Competitors

View All Competitors

Insiders

Richard E Allison Jr
Bought 20,000 shares on 5/11/2023
Total: $525,200.00 ($26.26/share)

View All Insider Transactions

KVUE Stock - Frequently Asked Questions

How have KVUE shares performed in 2023?: Kenvue's stock was trading at $26.50 on January 1st, 2023. Since then, KVUE shares have increased by 2.8% and is now trading at $27.23.
View the best growth stocks for 2023 here.
When did Kenvue IPO?: (KVUE) raised $3.3 billion in an initial public offering (IPO) on Thursday, May 4th 2023. The company issued 151,200,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan, BofA Securities, Citigroup, Deutsche Bank Securities, BNP PARIBAS, HSBC, RBC Capital Markets and UBS Investment Bank acted as the underwriters for the IPO.
What is Kenvue's stock symbol?: Kenvue trades on the New York Stock Exchange (NYSE) under the ticker symbol "KVUE."

When does the company's quiet period expire?: Kenvue's quiet period expires on Tuesday, June 13th. Kenvue had issued 172,812,560 shares in its public offering on May 4th. The total size of the offering was $3,801,876,320 based on an initial share price of $22.00. During the company's quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.
How do I buy shares of Kenvue?: Shares of KVUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Kenvue's stock price today?: One share of KVUE stock can currently be purchased for approximately $27.23.
How much money does Kenvue make?: Kenvue (NYSE:KVUE) has a market capitalization of $51.44 billion.

This page (NYSE:KVUE) was last updated on 5/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Kenvue (KVUE) Stock Forecast, Price & News

About Kenvue (NYSE:KVUE) Stock

KVUE Stock News Headlines

KVUE Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Competitors

Insiders

KVUE Stock - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info